PTIXProtagenic Therapeutics, Inc.\newvs its industry peers
A metric-by-metric comparison of Protagenic Therapeutics, Inc.\new against SIC 2834 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| 기업 | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| PTIX본 종목 | $1M#8 | 0.5x#7 | 0.8x#12 | — | — | 138.1%#1 | — | 79.4%#2 | — | — | — | — |
| MTNB | $2M#1 | — | 1.3x#14 | 2.2x#7 | -65.6%#7 | 57.3%#5 | -635.0%#4 | -574.7%#14 | — | — | -90.9%#4 | — |
| BTAI | $2M#2 | — | — | 3.6x#8 | -71.7%#9 | -17.3%#12 | -7860.0%#10 | — | — | — | -98.0%#7 | — |
| OGEN | $2M#3 | 0.5x#8 | 0.6x#11 | 61.1x#11 | -71.4%#8 | 6.9%#10 | -24865.2%#11 | -26814.1%#15 | — | — | -58.2%#1 | — |
| BFRGW | $2M#4 | — | 0.3x#9 | 17.8x#10 | — | 7.1%#9 | -5652.4%#9 | -93.0%#7 | -5287.3%#5 | — | -73.3%#3 | — |
| NXTS | $2M#5 | 0.0x#5 | 1.0x#13 | 9.1x#9 | -20.2%#6 | 22.9%#7 | -2014.3%#7 | -210.2%#10 | — | 4#2 | -97.4%#6 | — |
| DCOY | $2M#6 | 0.0x#6 | 0.4x#10 | — | -100.0%#10 | 124.4%#2 | — | 289.8%#1 | — | — | -95.9%#5 | — |
| ATXI | $1M#7 | — | 2.4x#15 | 1.0x#6 | — | 75.0%#3 | -219.6%#3 | -511.2%#13 | — | — | — | — |
| CDT | $164493#11 | 0.0x#2 | 0.0x#2 | — | — | -120.3%#15 | — | -38.0%#4 | — | — | — | — |
| BFRIW | $386161#9 | — | 0.1x#7 | 0.0x#2 | 11.7%#4 | 40.7%#6 | -27.2%#2 | -176.9%#9 | -712.4%#3 | — | — | — |
| SXTPW | $216295#10 | — | 0.1x#8 | 0.2x#5 | 65.5%#3 | 7.3%#8 | -771.6%#5 | -281.7%#11 | -163.8%#2 | 6#1 | — | — |
| SBFMW | $124463#12 | 0.0x#4 | 0.0x#4 | 0.0x#1 | 4.1%#5 | -16.4%#11 | -17.2%#1 | -21.7%#3 | -63.1%#1 | — | — | — |
| CINGW | $117789#13 | — | 0.0x#5 | — | — | -35.6%#13 | — | -95.7%#8 | — | — | — | — |
| KTTAW | $90219#14 | — | 0.0x#3 | 0.2x#4 | 3130.4%#1 | -46.9%#14 | -4286.7%#8 | -41.0%#6 | — | — | — | — |
| ERNAW | $58930#15 | 0.0x#3 | 0.0x#6 | 0.1x#3 | 755.9%#2 | 68.4%#4 | -1601.2%#6 | -440.1%#12 | -1016.2%#4 | — | — | — |
| CDTTW | $5271#16 | 0.0x#1 | 0.0x#1 | — | — | -120.3%#15 | — | -38.0%#4 | — | — | -59.4%#2 | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 2834). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. 이 표는 생성 중 시간이 초과되어 그룹의 일부만 포함합니다. 순위는 표시된 행 내에서만 유효하며 곧 채워집니다. Table built 2026-09-15.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice